ORIGINAL ARTICLE

Cell Research (2009): 710-719
© 2009 IBCB, SIBS, CAS All rights reserved 1001-0602/06 $ 30.00
www.nature.com/cr

Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling

Zan Tong¹, Yan Fan², Weiqi Zhang¹, Jun Xu¹, Jing Cheng³, Mingxiao Ding^1,4 and Hongkui Deng^1,4

Correspondence: Hongkui Deng, Tel: +86-10-6275-6474; Fax: +86-10-6275-6954 E-mail: hongkui_deng@pku.edu.cn

Download as printable (PDF) file Full Text (html)file Search Medline for articles by: Zan Tong

PTEN, a negative regulator of the phosphatidylinositol-3-kinase/AKT pathway, is an important modulator of insulin signaling. To determine the metabolic function of pancreatic Pten, we generated pancreas-specific Pten knockout (PPKO) mice. PPKO mice had enlarged pancreas and elevated proliferation of acinar cells. They also exhibited hypoglycemia, hypoinsulinemia, and altered amino metabolism. Notably, PPKO mice showed delayed onset of streptozotocin (STZ)-induced diabetes and sex-biased resistance to high-fat-diet (HFD)-induced diabetes. To investigate the mechanism for the resistance to HFD-induced hyperglycemia in PPKO mice, we evaluated AKT phosphorylation in major insulin-responsive tissues: the liver, muscle, and fat. We found that Pten loss in the pancreas causes the elevation of AKT signaling in the liver. The phosphorylation of AKT and its downstream substrate GSK3β was increased in the liver of PPKO mice, while PTEN level was decreased without detectable excision of Pten allele in the liver of PPKO mice. Proteomics analysis revealed dramatically decreased level of 78-kDa glucose-regulated protein (GRP78) in the liver of PPKO mice, which may also contribute to the lower blood glucose level of PPKO mice fed with HFD. Together, our findings reveal a novel response in the liver to pancreatic defect in metabolic regulation, adding a new dimension to understanding diabetes resistance.

Cell Research (2009) 19:710–719. doi: 10.1038/cr.2009.42; published online 14 April 2009

Keywords: Pten, pancreatic knockout, diabetes resistance, hepatic AKT signaling